Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/22/2012WO2012037226A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012037217A1 Transfer hydrogenation of cyclopamine analogs
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012037193A2 Formulations for treatment with glucosinolate
03/22/2012WO2012037187A2 Preparation of crystalline bazedoxifene and its salts
03/22/2012WO2012037155A2 Tyrosine kinase inhibitors
03/22/2012WO2012037132A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012WO2012037119A2 Inhibitors of viral entry into mammalian cells
03/22/2012WO2012037117A1 Aqueous drug delivery system comprising off - flavor masking agent
03/22/2012WO2012037108A1 Aminoquinoline derivatives as antiviral agents
03/22/2012WO2012037105A1 Methods of treating, ameliorating or preventing stress-induced neuronal disorders and diseases
03/22/2012WO2012037093A1 Compositions for treating cancer treatment - related fatigue
03/22/2012WO2012037072A1 Hsp90 inhibitors for treating non-small cell lung cancers in wild-type egfr and/or kras patients
03/22/2012WO2012037060A1 Substituted azaindoles
03/22/2012WO2012037047A1 Methods, compositions, and devices for managing chlorine dioxide release
03/22/2012WO2012037038A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
03/22/2012WO2012037034A1 E-selectin antagonists
03/22/2012WO2012037023A1 Methods of reducing blood lactate concentration
03/22/2012WO2012037008A2 Therapy for mll-rearranged leukemia
03/22/2012WO2012037000A1 Benzoyl peroxide composition, methods of making same, and pharmaceutical or cosmetic formulations comprising same, and uses thereof
03/22/2012WO2012036997A1 Fused pyrazole derivatives as novel erk inhibitors
03/22/2012WO2012036974A1 Novel thiazol-carboximide derivatives as pdk1 inhibitors
03/22/2012WO2012036919A2 Combination of braf and vegf inhibitors
03/22/2012WO2012036616A1 Treatment of fungal infections
03/22/2012WO2012036589A1 Hydrogel composition for the treatment of burns
03/22/2012WO2012036585A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
03/22/2012WO2012036529A2 (s)-n,n-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine derivatives, pharmaceutical compositions containing the derivatives and manufacturing methods thereof
03/22/2012WO2012036523A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012036518A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012036512A2 Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells
03/22/2012WO2012036507A2 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof
03/22/2012WO2012036433A2 Treatment of neurodegenerative diseases by targeting mirna
03/22/2012WO2012036430A2 Non-aqueous oily injectable formulation exhibiting preservative efficacy
03/22/2012WO2012036383A2 Use of a protein tyrosine kinase inhibitor for inducing the differentiation of mesenchymal stem cells into cardiogenic cells
03/22/2012WO2012036293A1 Diabetes therapeutic agent
03/22/2012WO2012036287A1 Novel cortistatin a analog and use thereof
03/22/2012WO2012036283A1 Cosmetic material, bathwater additive and pharmaceutical composition containing chitin nanofibers or chitosan nanofibers
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036276A1 Glycine transporter inhibitory substance
03/22/2012WO2012036268A1 Glycine transporter inhibitory substance
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012036214A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants
03/22/2012WO2012036208A1 Fat oxidation or energy metabolism enhancer
03/22/2012WO2012036180A1 Xanthone derivative and use thereof
03/22/2012WO2012036168A1 Composition for treating muscular dystrophy
03/22/2012WO2012036152A1 High purity heparin and production method therefor
03/22/2012WO2012036078A1 Drug-containing film-coated particles in which unpleasant taste is masked
03/22/2012WO2012035856A1 Collagen production promoter, hyaluronic acid production promoter, and wrinkle diminishing agent
03/22/2012WO2012035855A1 Collagen production promoter, hyaluronic acid production promoter and wrinkle ameliorating agent
03/22/2012WO2012035794A1 Octreotide-modified nano preparation for treatment of cancer or palliative care of cancer
03/22/2012WO2012035770A1 Osteogenesis promoting agent containing glycogen
03/22/2012WO2012035747A1 Cancer heat therapy-enhancing agent
03/22/2012WO2012035685A1 Composition for promoting hyaluronic acid production
03/22/2012WO2012035557A1 Novel cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof
03/22/2012WO2012035548A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
03/22/2012WO2012035544A2 A novel polymorphic form of rifaximin and process for its preparation
03/22/2012WO2012035518A1 Compositions and methods for treatment of drug resistant multiple myeloma
03/22/2012WO2012035516A1 Fulvestrant compositions and methods of use
03/22/2012WO2012035489A1 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
03/22/2012WO2012035480A2 Pharmaceutical compositions of curcumin
03/22/2012WO2012035478A2 Antifungal varnish composition
03/22/2012WO2012035436A1 Plinabulin prodrug analogs and therapeutic uses thereof
03/22/2012WO2012035423A1 Anti-cancer activity of novel bicyclic heterocycles
03/22/2012WO2012035421A2 Pyridine compounds and the uses thereof
03/22/2012WO2012035409A1 Sustained release compositions of anti-alzheimer's agents
03/22/2012WO2012035406A1 Tryptamine derivatives, their preparation and their use in gastropathy
03/22/2012WO2012035381A1 A novel dermaceutical cream made using sodium fusidate and betamethasone valerate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035380A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035379A1 A novel dermaceutical cream made using sodium fusidate, miconazole nitrate and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035378A1 A dermaceutical cream made using sodium fusidate, and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035377A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035376A1 A dermaceutical cream made using sodium fusidate, miconazole and mometasone furoate
03/22/2012WO2012035375A1 A novel dermaceutical cream made using sodium fusidate and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035374A1 A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
03/22/2012WO2012035364A1 Stabilized solution of ortho-silicic acid, its preparation and use
03/22/2012WO2012035346A1 Prodrugs of guanfacine
03/22/2012WO2012035321A1 Methods, compounds and compositions relating to activating a latent virus
03/22/2012WO2012035305A1 Bioactive alkaloids
03/22/2012WO2012035283A1 Pharmaceutical composition
03/22/2012WO2012035216A1 Dihydrobenzoxathiazepine derivatives, preparation thereof, pharmaceutical compositions and use as ampa receptor modulators
03/22/2012WO2012035171A2 New compounds
03/22/2012WO2012035158A1 Pyrazine derivatives as enac blockers
03/22/2012WO2012035147A1 Nuclear export inhibitors
03/22/2012WO2012035131A1 Treatment of abl overexpressing b-cell lymphoma
03/22/2012WO2012035124A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
03/22/2012WO2012035123A1 Arylosulfonamides for the treatment of cns diseases
03/22/2012WO2012035122A1 Anthraquinone compounds and their uses
03/22/2012WO2012035078A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
03/22/2012WO2012035075A1 Substituted phenylacetate and phenylpropane amides and use thereof
03/22/2012WO2012035055A1 Novel compounds
03/22/2012WO2012035039A1 Azabenzothiazole compounds, compositions and methods of use
03/22/2012WO2012035023A1 Triazine-oxadiazoles
03/22/2012WO2012034969A1 Gt aptamer oligonucleotides and use thereof as antitumor agents
03/22/2012WO2012034955A1 Treatment of bacterial infectious diseases
03/22/2012WO2012034954A1 Substituted hexahydropyrrolo [1, 2 - c] imidazolones useful as mdm2 inhibitors
03/22/2012WO2012034942A1 Compounds for the modulation of aurora kinase b expression
03/22/2012WO2012034719A1 Novel antiviral acyclic nucleoside phosphonates
03/22/2012WO2012034540A1 Anti-tumor pharmaceutical composition
03/22/2012WO2012034526A1 Fused heteroaryls and their uses
1 ... 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 ... 7860